12-02 :: February/March 2012
nanotimes
Companies Facts
M
agForce AG (Frankfurt, XETRA: MF6) has completed a share placement with institutio-
nal investors. All of the 825,408 newly issued shares were placed, with profit participation rights dating from January 1, 2011, at a price of EUR5.50 per share. The gross proceeds from the capital increase, in the amount of EUR 4,539,744.00 will be used for further commercialization activities and the clinical development of the NanoTherm®
technology along
with the expansion of commercial and strategic part- nerships.
This transaction increases the nominal share capital of the company, from EUR4.127.041, divided into 4,127,041 shares with an imputed nominal value of EUR1.00, to EUR 4,952,495.00.
The very successful capital increase and the meetings with the strategic investors were managed by Silvia Quandt & Cie. AG.
http://www.magforce.com
lithium-ion batteries. The transaction additionally co- vers Merck’s respective research portfolio regarding novel electrolytes and additives.
http://www.merck.de M
etabolix, Inc. (NASDAQ: MBLX) reported financial results for the three months and full
year ended December 31, 2011. Total revenue in the fourth quarter of 2011 was $0.4 million, com- pared to $0.1 million for the comparable quarter in 2010. Total revenue for the full year 2011 was $1.4 million, compared to $0.4 million, for the compara- ble quarter in 2010.
For the full year, the Company reported a net loss of $38.8 million or $1.24 per share as compared to a net loss of $38.8 million or $1.45 per share for 2010.
M
erck sells its electrolytes business for high- performance batteries to BASF. The compa-
nies have agreed not to disclose the financial details of the transaction.
The divestment encompasses the tec hnologies and products for enhancing battery performance that Merck has developed, patented and in some cases brought to market. These include the complete line of finished electrolyte formulations that are marke- ted under the SelectiLyte®
variety of additives for electrolytes used to produce
Net cash used in operating activities for the full year was $31.7 million compared to $32.0 million used in 2010. Unrestricted cash and investments at De- cember 31, 2011 totaled $78.4 million. In 2011, the Company raised $49.3 million net proceeds in an offering of common stock and continues to have no debt.
http://www.metabolix.com M brand. Also included is a
ETACLAY, a business based in Karachev, Bry- ansk Oblast, has launched the first production
in Russia of nanosilicates and polymer nanocom- posites incorporating those nanosilicates. The pro- ducts are used as additives and fillers in the oil-and- gas, cable, packaging, and automobile industries.
31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89